SION: Rega marang dodolan Sionna Pharma

Sionna Therapeutics Inc (SION) is recruiting top biochemists to develop genetics patents. This chart illustrates the revenue valuation based on GURU.Markets data, where the current value stands at . The company is developing treatments for cystic fibrosis, aiming to generate profit from the restoration of protein functions; however, the lack of finished products and the costs of testing are limiting the business's scalability.
Rincian analitis perusahaan Sionna Therapeutics, Inc. (SION)

For the biotech sector company Sionna Therapeutics Inc (SION), which focuses on CFTR protein restoration for cystic fibrosis, valuation is based on future market prospects. By analyzing the price-to-sales multiple, an investor compares the asset's current market price with actual sales volume to determine the premium paid for the therapy's potential and minimize the risk of a deep correction driven by inflated expectations.